Opening a hospital is only the first funding challenge. Its wards, staff and equipment need support every day. That is the operating question behind Tata Trusts’ ambition to build a network of not-for-profit general hospitals.
The Breakdown
In his message accompanying the Trusts’ 2025–26 annual report, chairman Noel Tata says the organisation is working towards 40–50 general hospitals. The proposed model would use payments from people who can afford care to help make treatment accessible to those who cannot. The message also calls for measuring lasting changes in people’s lives, rather than spending or reach alone.
This is a stated ambition, not a count of hospitals already opened. The chairman’s message does not provide a project-by-project timetable, bed capacity or funding breakdown. Nor is the hospital concept entirely new: the Trusts’ account of an August 2, 2026 event already described the proposal.
Why This Matters
Cross-subsidy means using a surplus from one group of services or customers to help cover another group’s costs. For a hospital, the practical question is whether paying activity produces enough surplus after its own costs, and whether that support remains dependable as demand changes.
A simple illustration shows the difference. A paying patient’s bill is revenue. Only the amount left after providing that care can contribute towards another patient’s treatment, unless a donor or another funding source meets the gap. Counting paying and subsidised patients alone therefore cannot establish whether the model balances financially.
An Indian Operating Example
Aravind Eye Care offers a useful comparison. In its own description of its model, it links affordable treatment to high patient volumes, organised clinical workflows and economies of scale. It says around half its patients receive free or heavily subsidised services while the organisation remains financially self-sustaining. These are the provider’s statements, rather than an independent financial assessment.
Its 2025–26 activity report records 802,003 surgeries, laser procedures and injections: 413,198 in paying sections, 284,216 for subsidised walk-in patients and 104,589 free through screening camps. These are treatment-activity counts, not a count of unique patients or a measure of the financial subsidy.
The comparison has limits. An eye-care system and a network of general hospitals treat different combinations of conditions and use different staffing, equipment and emergency capacity. Aravind’s experience offers questions to investigate; it does not establish what Tata Trusts’ hospitals will cost or achieve.
The Big Picture
The useful measures would go beyond the number of buildings. How much care reaches patients who otherwise could not afford it? What do they still pay? How long do they wait? Are treatment outcomes comparable across payment groups? And what proportion of recurring costs is covered by patient revenue, insurance, donations or endowment income? These are editorial questions for assessing the proposed model, not results already reported.
The Crunch
The promise is broader access to care. The test will be an operating model that keeps that access affordable and dependable after the opening ceremony.